4-Guanidino-methylphenylalanine | 1991-97-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-Guanidino-methylphenylalanine
• 英文别名: (2S)-2-amino-3-[4-[(diaminomethylideneamino)methyl]phenyl]propanoic acid
• CAS: 1991-97-5
• 化学式: C₁₁H₁₆N₄O₂
• 分子量: 236.27
• InChiKey: OSPFMSZZQUXLEB-VIFPVBQESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.1
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  128
• 氢给体数：
  4
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-胍基-3-苯基丙酸 、 L-arginyl-L-phenylalanine 、 4-Guanidino-methylphenylalanine 、 苯丙氨酸酰肼 、 2-(2-amino-3-phenylpropanamido)-N-(naphthalen-2-yl)-5-guanidinopentanamide 、 H-Arg-Arg-Trp-Cys-Phe-Arg-Val-Cys-Tyr-Arg-Gly-Phe-Cys-Tyr-Arg-Lys-Cys-Arg-NH2 、 生成 4-胍基-L-苯丙氨酸
  参考文献：
  名称：

  DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION

  摘要：

  本发明涉及溶解化合物、用于从油、脂肪、水乳液、水介质和有机溶液中溶解和去除羧酸，特别是脂肪酸的装置和方法。采用本发明方法的装置将用于通过制备羧酸特别是脂肪酸和含有至少一种氨基甲酰基和/或肼基团的溶解化合物的水微观或纳米乳液，分离油、脂肪、水乳液、亲脂性介质或有机溶液中的羧酸。溶解化合物的溶解效果与本发明所述的羧酸分离方法相结合，可用于治疗需要去除脂肪酸或从血液中分析羧酸或处理食品、药品、化学、生物燃料工业或其他工业加工过程中的其他溶液的人员。

  公开号：

  US20130090488A1

文献信息

• Inhibitors of the blood-clotting factor xa, production thereof and use of the same
  申请人：Sturzebecher Jorg

  公开号：US20050119190A1

  公开（公告）日：2005-06-02

  The invention relates to novel inhibitors of clotting factor Xa, the preparation and use thereof for therapy, prophylaxis and diagnosis of cardiovascular disorders and thromboembolic events.

  本发明涉及一种新型凝血因子Xa抑制剂，其制备和用途用于治疗、预防和诊断心血管疾病和血栓栓塞事件。
• Device and method for solubilizing, separating, removing and reacting carboxylic acids in oils, fats, aqueous or organic solutions by means of micro-or nanoemulsification
  申请人：Dietz Ulrich

  公开号：US09127233B2

  公开（公告）日：2015-09-08

  The present invention is directed to solubilizing compounds, a device and a method for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the inventive method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings.

  本发明涉及可溶化化合物、用于从油、脂肪、水乳液、水介质和有机溶液中溶解和去除羧酸，特别是脂肪酸的装置和方法。采用本发明方法的装置将用于通过制备羧酸，特别是脂肪酸和含有至少一种酰胺基和/或氨基甲酸基团的可溶化化合物的水微观或纳米乳液，分离油、脂肪、水乳液、亲脂性介质或有机溶液中的羧酸。可溶化化合物的溶解效果与本发明用于羧酸的分离方法相结合，可用于治疗需要去除脂肪酸或分析血液中的羧酸或处理食品、药品、化学品、生物燃料工业或其他工业加工中的其他溶液的人。
• Device and method for solubilizing, separating, removing and reacting carboxylic acids in aqueous or organic solutions by means of micro- or nanoemulsification
  申请人：Dietz, Ulrich

  公开号：EP2399885A1

  公开（公告）日：2011-12-28

  The invention is related to the emulsification effects achiveable by arginine and arginine analogues on carboxylic acids in aqueous and organic media and the use of these effects to solubilize, separate and remove carboxylic acids as well as increasing physical or chemical interactions and reactions. Furthermore, the invention is directed to the nanoemulsifying properties of arginine and arginine analogues on carboxlic acids and poorly soluble molecules. Solubilization effects of arginine and arginine analogues combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry or other industrial processings. The inventive effects of arginine and arginine analogues enable the use of methods for nano-filtration of carboxylic acids. Moreover, the use of arginine and arginine anlogues as well as carboxylic acids used to functionalize the interface of micro- and nanofluidic separation media including hydro- or organogels by means of surface functionalization, adsorption or incorporation enables the use of electrophoretic and nanofiltration techniques to be applied on carboxylic acids.

  本发明涉及精氨酸和精氨酸类似物在水性和有机介质中对羧酸的乳化作用，以及利用这些作用来增溶、分离和去除羧酸以及增加物理或化学相互作用和反应。此外，本发明还涉及精氨酸和精氨酸类似物对羧酸和难溶分子的纳米乳化特性。精氨酸和精氨酸类似物的增溶作用与羧酸分离方法的创造性使用相结合，可用于治疗需要去除脂肪酸的人，或分析血液中的羧酸，或处理食品、制药、化学或其他工业加工中的其他溶液。精氨酸和精氨酸类似物的创造性作用使得纳米过滤羧酸的方法得以使用。此外，使用精氨酸和精氨酸类似物以及羧酸，通过表面官能化、吸附或结合的方式，使包括水凝胶或有机凝胶在内的微流体和纳米流体分离介质的界面功能化，可将电泳和纳滤技术应用于羧酸。
• DEVICE FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO- OR NANOEMULSIFICATION
  申请人：Dietz, Ulrich

  公开号：EP3042718A1

  公开（公告）日：2016-07-13

  The present invention is directed to a device for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the herein disclosed method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the use of the separation methods for carboxylic acids as discloses herein can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings.

  本发明涉及一种从油、脂肪、水乳液、水介质和有机溶液中增溶和去除羧酸，特别是脂肪酸的装置。通过制备羧酸（尤其是脂肪酸）和至少含有一个脒基和/或胍基的增溶化合物的水性微乳液或纳米乳液，利用本文公开的方法制备的设备可分别用于从油、脂肪、水性乳液、亲油介质或有机溶液中分离羧酸。增溶化合物的增溶作用与本文公开的羧酸分离方法相结合，可用于治疗需要从血液中去除脂肪酸或分析羧酸的人，或处理食品、制药、化学、生物燃料工业或其他工业加工中的其他溶液。
• AMINOACID DERIVATIVES AS NO SYNTHASE INHIBITORS
  申请人：THE WELLCOME FOUNDATION LIMITED

  公开号：EP0705257B1

  公开（公告）日：1998-03-11